Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BCD-121 in healthy volunteers
NCT03103451Phase 1Completed
- Sponsor
- BIOCAD
- Start
- Nov 2016
- Primary completion
- May 2017
- Modality
- Bispecific Antibodies, Monoclonal Antibodies
01
Overview
Phase 1, randomised, single-blind trial in autoimmune disorder comparing BCD-121 Cohorts with Placebo (2 arms). Primary endpoint: Area Under the Plasma Concentration of BCD-121-time Curve From Zero (0) Hours to 2160 Hours. Started Nov 2016; status: completed.
02
Drugs
BCD-121
03
Conditions
autoimmune disorder
Beyond the preview
Go deeper on NCT03103451.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03103451.